Affymetrix Shares Drop 14.2 Percent | GenomeWeb
Shares of Affymetrix dropped 14.2 percent for the five-day trading period ended Tuesday. The firm’s shares fell 9.6 percent on Tuesday alone after it said it had filed a shelf registration to offer $250 million of senior convertible notes (see Briefs).
 
Canaccord Adams analyst Matthew Scalo speculated in an interview with Reuters that Affymetrix may be looking for a “sizeable acquisition.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.